H. Ghofrani, Giessen, Germany
University of Giessen and Marburg Lung CenterPoster Author Of 1 e-Poster
Oral
PH - Therapeutics and Pharmacology
502 - Ralinepag, an Oral, Selective, Prostacyclin (IP) Receptor Agonist Consistently Improved Mortality Risk Scores Derived From PAH Registries Across Three Regions: Phase 2 Study Analysis
Presentation Number
502
Co-Authors
- R. Benza, Pittsburgh, PA, United States of America
- H. Ghofrani, Giessen, Germany
- M. Gomberg-Maitland, Chicago, IL, United States of America
- P. Klassen, San Diego, CA, United States of America
- E. Parsley, San Diego, CA, United States of America
- O. Sitbon, Le Kremlin-BicĂȘtre, France
- F. Torres, Dallas, TX, United States of America
- J. Zhang, San Diego, CA, United States of America